Literature DB >> 36266394

Structure-function correlates of vision loss in neuromyelitis optica spectrum disorders.

Alexander U Brandt1,2, Hanna G Zimmermann3,4,5, Norman K Gigengack1,6, Frederike C Oertel1,6,7, Seyedamirhosein Motamedi1,6, Charlotte Bereuter1,6, Ankelien Duchow1,6, Rebekka Rust1,6, Judith Bellmann-Strobl1,6, Klemens Ruprecht8, Tanja Schmitz-Hübsch1,6, Friedemann Paul1,6,8.   

Abstract

Optic neuritis (ON) in neuromyelitis optica spectrum disorders (NMOSD) regularly leads to more profound vision loss compared to multiple sclerosis (MS) and myelin-oligodendrocyte-glycoprotein-antibody associated disease (MOGAD). Here we investigate ON-related vision loss in NMOSD compared to MS and MOGAD in order to identify neuroaxonal and retinal contributors to visual dysfunction. In this retrospective study we included patients with aquaporin-4-antibody seropositive NMOSD (n = 28), MOGAD (n = 14), MS (n = 29) and controls (n = 14). We assessed optic nerve damage and fovea morphometry by optical coherence tomography. Visual function was assessed as high (HCVA) and low contrast visual acuity (LCVA), and visual fields' mean deviation (MD). In all diseases, lower visual function was associated with peripapillary retinal nerve fiber layer (pRNFL) and ganglion cell and inner plexiform layer (GCIP) thinning following a broken stick model, with pRNFL and GCIP cutoff point at ca. 60 µm. HCVA loss per µm pRNFL and GCIP thinning was stronger in NMOSD compared with MOGAD. Foveal inner rim volume contributed to MD and LCVA in NMOSD eyes, only. Together these data supports that visual dysfunction in NMOSD is associated with neuroaxonal damage beyond the effect seen in MS and MOGAD. A primary retinopathy, respectively Müller cell pathology, may contribute to this effect.
© 2022. The Author(s).

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36266394      PMCID: PMC9585067          DOI: 10.1038/s41598-022-19848-4

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.996


  48 in total

1.  Frequent retinal ganglion cell damage after acute optic neuritis.

Authors:  Alexander U Brandt; Svenja Specovius; Timm Oberwahrenbrock; Hanna G Zimmermann; Friedemann Paul; Fiona Costello
Journal:  Mult Scler Relat Disord       Date:  2018-04-09       Impact factor: 4.339

2.  Evidence of Müller Glial Dysfunction in Patients with Aquaporin-4 Immunoglobulin G-Positive Neuromyelitis Optica Spectrum Disorder.

Authors:  Yuyi You; Ling Zhu; Ting Zhang; Ting Shen; Ariadna Fontes; Con Yiannikas; John Parratt; Joshua Barton; Angela Schulz; Vivek Gupta; Michael H Barnett; Clare L Fraser; Mark Gillies; Stuart L Graham; Alexander Klistorner
Journal:  Ophthalmology       Date:  2019-02-01       Impact factor: 12.079

3.  Visual field loss and structure-function relationships in optic neuritis associated with myelin oligodendrocyte glycoprotein antibody.

Authors:  Romain Deschamps; Manon Philibert; Cedric Lamirel; Jerome Lambert; Vivien Vasseur; Antoine Gueguen; Caroline Bensa; Augustin Lecler; Romain Marignier; Catherine Vignal; Olivier Gout
Journal:  Mult Scler       Date:  2020-07-07       Impact factor: 6.312

Review 4.  Clinical Characteristics and Treatment of MOG-IgG-Associated Optic Neuritis.

Authors:  Deena A Tajfirouz; M Tariq Bhatti; John J Chen
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-26       Impact factor: 5.081

5.  Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).

Authors:  J F Kurtzke
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910

Review 6.  Neuromyelitis optica: clinical features, immunopathogenesis and treatment.

Authors:  S Jarius; B Wildemann; F Paul
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

7.  The OSCAR-IB consensus criteria for retinal OCT quality assessment.

Authors:  Prejaas Tewarie; Lisanne Balk; Fiona Costello; Ari Green; Roland Martin; Sven Schippling; Axel Petzold
Journal:  PLoS One       Date:  2012-04-19       Impact factor: 3.240

Review 8.  Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy.

Authors:  Frederike C Oertel; Hanna Zimmermann; Friedemann Paul; Alexander U Brandt
Journal:  EPMA J       Date:  2017-12-22       Impact factor: 6.543

9.  Altered fovea in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders.

Authors:  Seyedamirhosein Motamedi; Frederike C Oertel; Sunil K Yadav; Ella M Kadas; Margit Weise; Joachim Havla; Marius Ringelstein; Orhan Aktas; Philipp Albrecht; Klemens Ruprecht; Judith Bellmann-Strobl; Hanna G Zimmermann; Friedemann Paul; Alexander U Brandt
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-06-23

10.  Differences in morphology and visual function of myelin oligodendrocyte glycoprotein antibody and multiple sclerosis associated optic neuritis.

Authors:  Rino Vicini; Dominik Brügger; Mathias Abegg; Anke Salmen; Hilary Michelle Grabe
Journal:  J Neurol       Date:  2020-08-12       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.